As a treatment for osteoporosis, generics have begun to be released in the latest bone formation promoting agents. Following Lilly's Forsteo, Dong-A ST's Teribone was also a generic version.

The MFDS approved Terrosa 56.5μg (Teriparatide acetate) from BMIKOREA on the 28th. Terrosa is a generic of Teribone subcutaneous injection 56.5 μg and the same ingredient (Teriparatide acetate), which was approved by Dong-A ST in November 2015.

This is the first time Generic for Teribone has been licensed. Teribone is a partially synthesized formulation of parathyroid hormone involved in bone formation, and is a product introduced in Korea by Dong-A ST from Asahi Kasei Pharma in Japan.